Basic info
Industry
biotechnology research
Sectors
Biotechnology
biotechnology
Gene Therapy
adeno associated virus
SF9
ALS
CNS
gene therapy
Neuropharmacology
Parkinson's Disease
Research
Tauopathies
Neurology
Health Care
Amyotrophic Lateral Sclerosis
Huntington's Disease
Genetics
SOD-1
Friedrich's Ataxia
Alzheimer's disease
vector engineering
Life Science
Date founded
2014
Funding rounds raised
Total raised
$60M
from 6 investors over 6 rounds
V
Voyager Therapeutics, Inc. raised $39M on January 9, 2023
Investors: Neurocrine Biosciences
V
Voyager Therapeutics, Inc. raised $60M on April 13, 2015
Investors: -, Brookside Capital Inc and Casdin Capital, LLC
V
Voyager Therapeutics, Inc. raised $30M on February 11, 2015
Investors: Genzyme
V
Voyager Therapeutics, Inc. raised $45M on February 12, 2014
Investors: Third Rock Ventures